Tech Company Financing Transactions

Arixa Pharmaceuticals Funding Round

Arixa Pharmaceuticals secured a $8 million Seed funding round on 5/2/2018. Investors included private investors.

Transaction Overview

Announced On
5/2/2018
Transaction Type
Venture Equity
Amount
$8,000,000
Round
Seed
Investors
Proceeds Purpose
With the completion of the financing, the company intends to conduct a Phase 1 human clinical study of its lead candidate, ARX-1796, a proprietary, orally available prodrug of Avibactam, an FDA-approved beta-lactamase inhibitor that previously could be delivered only by intravenous injection.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Palo Alto, CA 94020
USA
Phone
Undisclosed
Email Address
Overview
Arixa Pharmaceuticals is developing oral antibiotics for resistant Gram-negative infections using our proprietary prodrug technology. We have successfully created a series of safe oral prodrugs of avibactam, a ß-lactamase inhibitor approved by FDA in 2015 as component of AVYCAZ.
Profile
Arixa Pharmaceuticals LinkedIn Company Profile
Social Media
Arixa Pharmaceuticals Company Twitter Account
Company News
Arixa Pharmaceuticals News
Facebook
Arixa Pharmaceuticals on Facebook
YouTube
Arixa Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
John Freund
  John Freund LinkedIn Profile  John Freund Twitter Account  John Freund News  John Freund on Facebook
Chief Scientific Officer
Eric Gordon
  Eric Gordon LinkedIn Profile  Eric Gordon Twitter Account  Eric Gordon News  Eric Gordon on Facebook
Co-Founder
Joaquim Trias
  Joaquim Trias LinkedIn Profile  Joaquim Trias Twitter Account  Joaquim Trias News  Joaquim Trias on Facebook


 

 

Browse more venture capital transactions:

Prev: 5/2/2018: SkyKick venture capital transaction
Next: 5/2/2018: OwnerIQ venture capital transaction

 

Share this article

 


About Database of VC Transactions

We do our best to document all VC transactions involving tech companies. VC investment data records reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary